The Informatics Core develops and supports informatics applications and shared informatics resources forCancer Center investigators. Many Cancer Center programs and cores have projects requiring complexinformation systems, including tissue and specimen tracking, related clinical and patient follow-upinformation, clinical trials data management, microarray data and metadata management and analysis.
The aims of the Core are to develop, deploy, and maintain data systems and applications to directly supportthe translational research goals of the Center. The Core develops data systems that span a range of users,from individual investigators, to individual programs within the Cancer Center, and to the Cancer Center as awhole. It works with researchers, Cancer Center administration, and other cores to fulfill its goals.Services of the Core include: (1) design and implementation of data models, (2) design and implementationof user interfaces, (3) maintenance of databases and associated web sites, and (4) custom data servicesinvolving specific programming expertise. These capabilities are offered on a recharge basis, both for shortand long-term projects.PERFORMANCE SITE(S) (organization, city, state)UCSF Comprehensive Cancer CenterSan Francisco, CaliforniaPHS 398 (Rev. 04/06) - Page 2 Form Page 2PHS 398/2590 (Rev. 09/04) Page 1 1 O 1 Informatics

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA082103-09
Application #
7506559
Study Section
Subcommittee G - Education (NCI)
Project Start
2007-09-25
Project End
2012-05-31
Budget Start
2007-09-25
Budget End
2008-05-31
Support Year
9
Fiscal Year
2007
Total Cost
$399,244
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Dvorak, Christopher C; Satwani, Prakash; Stieglitz, Elliot et al. (2018) Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study. Pediatr Blood Cancer 65:e27034
Fan, Qi Wen; Nicolaides, Theodore P; Weiss, William A (2018) Inhibiting 4EBP1 in Glioblastoma. Clin Cancer Res 24:14-21
Sannino, Sara; Guerriero, Christopher J; Sabnis, Amit J et al. (2018) Compensatory increases of select proteostasis networks after Hsp70 inhibition in cancer cells. J Cell Sci 131:
Lam, Christine; Ferguson, Ian D; Mariano, Margarette C et al. (2018) Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment. Haematologica 103:1218-1228
Truillet, Charles; Parker, Matthew F L; Huynh, Loc T et al. (2018) Measuring glucocorticoid receptor expression in vivo with PET. Oncotarget 9:20399-20408
Phillips, Kathryn A; Trosman, Julia R; Deverka, Patricia A et al. (2018) Insurance coverage for genomic tests. Science 360:278-279
Phillips, Kathryn A (2018) Evolving Payer Coverage Policies on Genomic Sequencing Tests: Beginning of the End or End of the Beginning? JAMA 319:2379-2380
Puri, Sapna; Roy, Nilotpal; Russ, Holger A et al. (2018) Replication confers ? cell immaturity. Nat Commun 9:485
An, Zhenyi; Aksoy, Ozlem; Zheng, Tina et al. (2018) Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies. Oncogene 37:1561-1575
Behr, Spencer C; Villanueva-Meyer, Javier E; Li, Yan et al. (2018) Targeting iron metabolism in high-grade glioma with 68Ga-citrate PET/MR. JCI Insight 3:

Showing the most recent 10 out of 192 publications